Sanofi (SNY) Cash from Discontinued Operations (2019 - 2025)

Sanofi has reported Cash from Discontinued Operations for 7 years, with the latest figure at 216512093.73 in Q4 2025.

• Quarterly Cash from Discontinued Operations changed N/A year-over-year to 216512093.73 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 200095708.73 (changed N/A YoY) and the FY2025 annual result came in at 220004224.28, down 56.57% from the prior year.
• Cash from Discontinued Operations declined to 216512093.73 in Q4 2025 per SNY's latest filing, from 218613302.08 in the prior quarter.
• Over five years, Cash from Discontinued Operations peaked at 12036862347.84 in Q4 2021 and troughed at 216512093.73 in Q4 2025.
• A 5-year average of 3683393063.94 and a median of 194598621.31 in 2025 frame the typical range for Cash from Discontinued Operations.
• The sharpest annual moves came in 2021 and 2025: Cash from Discontinued Operations surged 36.1% in 2021, then tumbled 93.69% in 2025.
• Over 5 years, Cash from Discontinued Operations stood at 12036862347.84 in 2021, then dropped by 10.78% to 10739123767.12 in 2022, then dropped by 7.11% to 9975038896.17 in 2023, then slumped by 99.46% to 53844378.81 in 2024, then plunged by 502.11% to 216512093.73 in 2025.
• According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 216512093.73, 218613302.08, and 3395879.06 for Q4 2025, Q3 2025, and Q2 2025 respectively.